Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.
2.

Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.

Bachman KE, Park BH.

Curr Opin Oncol. 2005 Jan;17(1):49-54. Review.

PMID:
15608513
3.

Role of transforming growth factor beta in cancer.

Pasche B.

J Cell Physiol. 2001 Feb;186(2):153-68. Review.

PMID:
11169452
4.

Role of tissue stroma in cancer cell invasion.

De Wever O, Mareel M.

J Pathol. 2003 Jul;200(4):429-47. Review.

PMID:
12845611
5.

The TGF-beta family: signaling pathways, developmental roles, and tumor suppressor activities.

Johnson AN, Newfeld SJ.

ScientificWorldJournal. 2002 Apr 5;2:892-925. Review.

6.

Development of TGF-beta resistance during malignant progression.

Kim YS, Yi Y, Choi SG, Kim SJ.

Arch Pharm Res. 1999 Feb;22(1):1-8. Review.

PMID:
10071951
7.

TGF-beta signaling in cancer--a double-edged sword.

Akhurst RJ, Derynck R.

Trends Cell Biol. 2001 Nov;11(11):S44-51. Review.

PMID:
11684442
8.

Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.

Achyut BR, Yang L.

Gastroenterology. 2011 Oct;141(4):1167-78. doi: 10.1053/j.gastro.2011.07.048. Epub 2011 Aug 11. Review.

PMID:
21839702
9.

[TGF-beta: usage in nephrology].

Quirin N, Feige JJ, Zaoui P.

Nephrologie. 1996;17(4):227-35. Review. French.

PMID:
8768454
10.

The transforming growth factor-beta signaling pathway in tumorigenesis.

Wieser R.

Curr Opin Oncol. 2001 Jan;13(1):70-7. Review.

PMID:
11148690
11.

Tumor-suppressive and promoting function of transforming growth factor beta.

Sun L.

Front Biosci. 2004 May 1;9:1925-35. Review.

PMID:
14977598
12.

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

Kirkbride KC, Blobe GC.

Expert Opin Biol Ther. 2003 Apr;3(2):251-61. Review.

PMID:
12662140
13.

Therapeutic strategies to target TGF-β in the treatment of bone metastases.

Buijs JT, Juárez P, Guise TA.

Curr Pharm Biotechnol. 2011 Dec;12(12):2121-37. Review.

PMID:
21619539
14.

Role of transforming growth factor-beta in cancer progression.

Galliher AJ, Neil JR, Schiemann WP.

Future Oncol. 2006 Dec;2(6):743-63. Review.

PMID:
17155901
15.

[Cystatin C--modulator of immune processes].

Wittek N, Majewska E.

Przegl Lek. 2010;67(7):484-7. Review. Polish.

PMID:
21387761
16.

Cystatins.

Abrahamson M, Alvarez-Fernandez M, Nathanson CM.

Biochem Soc Symp. 2003;(70):179-99. Review.

PMID:
14587292
17.

Epigenetic regulation of cystatins in cancer.

Rivenbark AG, Coleman WB.

Front Biosci (Landmark Ed). 2009 Jan 1;14:453-62. Review.

PMID:
19273077
18.

Transforming growth factor beta in infectious disease: always there for the host and the pathogen.

Fitzpatrick DR, Bielefeldt-Ohmann H.

Trends Microbiol. 1999 Jun;7(6):232-6. Review.

PMID:
10366859
19.

Cystatins and cancer.

Cox JL.

Front Biosci (Landmark Ed). 2009 Jan 1;14:463-74. Review.

PMID:
19273078
20.

Detection of TGF-beta in body fluids and tissues.

Limper AH.

Methods Mol Biol. 2000;142:39-54. Review. No abstract available.

PMID:
10806612

Supplemental Content

Support Center